Skip to main content
. 2022 Mar 10;12:858276. doi: 10.3389/fonc.2022.858276

Table 1.

Patients characteristics at admission.

No cancer (n=315) Cancer patients (n=105) Hematological maligancies (n=51) Solid tumors (n=54)
Sex
 Female 96 (30·6%) 33 (31·4%) 19 (37·3%) 14 (25·9%)
 Male 218 (69·4%) 72 (68·6%) 32 (62·7%) 40 (74·1%)
Age, Years 67 (59 - 75) 69 (65 - 73) 69 (64 - 72) 69 (65 - 73)
BMI, kg/m² 28 (25 - 32) 26 (23 - 29) 25 (23 - 28) 26 (23 - 29)
Diabetes mellitus 107 (34·0%) 24 (22·9%) 9 (17·6%) 15 (27·8%)
Chronic kidney disease 32 (10·2%) 12 (11·4%) 8 (15·7%) 4 (7·4%)
Congestive heart failure 29 (9·2%) 10 (9·5%) 4 (7·8%) 6 (11·1%)
Chronic respiratory disease 12 (3·8%) 8 (7·6%) 4 (7·8%) 4 (7·4%)
Cirrhosis (Child B or C) 8 (2·5%) 1 (1·0%) 0 (0%) 1 (1·9%)
Solid organ transplant 11 (3·5%) 1 (1·0%) 0 (0%) 1 (1·9%)
Immunosuppressive agents 17 (5·4%) 26 (24·8%) 18 (35·3%) 8 (14·8%)
HIV 6 (1·9%) 3 (2·9%) 1 (2·0%) 2 (3·7%)
<3 months hospitalization 32 (10·2%) 42 (40·0%) 22 (43·1%) 20 (37·0%)
Recent antimicrobial treatments 83 (26·4%) 50 (47·6%) 27 (52·9%) 23 (42·6%)
Pre-admission location
Home 127 (40·3%) 31 (29·5%) 13 (25·5%) 18 (33·3%)
Non-ICU units 157 (49·8%) 59 (56·2%) 30 (58·8%) 29 (53·7%)
Intensive car units 31 (9·8%) 15 (14·3%) 8 (15·7%) 7 (13·0%)
SAPS II score 36 (28 - 45) 43 (36 - 58) 47 (37 - 58) 41 (35 - 56)
SOFA score 4 (3 - 7) 6 (3 - 8) 6 (4 - 8) 4 (3 - 8)
SARS-Cov-2 diagnosis
PCR 306 (97·8%) 100 (96·2%) 50 (98·0%) 50 (94·3%)
Serology 2 (0·6%) 1 (1·0%) 0 (0%) 1 (1·9%)
CT-scan 5 (1·6%) 3 (2·9%) 1 (2·0%) 2 (3·8%)
PaO2 at admission 70 (59 - 85) 67 (58 - 82) 67 (56 - 93) 66 (59 - 77)
pH at admission 7·45 (7·40 - 7·48) 7·45 (7·41 - 7·48) 7·45 (7·40 - 7·48) 7·45 (7·42 - 7·48)
Lactate at admission 1·3 (1·0 - 1·8) 1·4 (1·0 - 2·0) 1·2 (1·0 - 1·9) 1·5 (1·1 - 2·1)

BMI, Body mass index; HIV, Human immunodeficiency virus; ICU, intensive care units; SAPS II score, simplified acute physiology score; SOFA score, Sepsis-related Organ Failure Assessment; PCR, polymerase chain reaction; CT, computed tomography.